glp-1 weight-loss drugs How medications are transforming diabetes and weight loss treatment GLP-1: Genetic Variants Related to

Some GLP1 receptor agonists are approved for weight management in individuals without diabetes, but clinicians should weigh benefits, risks, and access considerations for each patient

That sets the stage for weight regain. GLP-1 medications temporarily blunt that biological pushback

Results When comparing 68 patients on acetazolamide alone to 11 patients on combined therapy with acetazolamide and GLP-1 agonists, no significant differences were found in any of the parameters: papilledema grade, best corrected visual acuity (BCVA), visual field (VF) or OCT RNFL thickness improvements over a 12-month period

Theyre both used for type 2 diabetes and weight loss, but work slightly differently